How much funding has 20/20 Onsite raised?

20/20 Onsite has raised $8.0M in total funding, most recently a Series A round.

Who are 20/20 Onsite's investors?

20/20 Onsite's investors include Morningside Group.

Where is 20/20 Onsite headquartered?

20/20 Onsite is headquartered in United States.

What industry is 20/20 Onsite in?

20/20 Onsite operates in Healthcare.

How many employees does 20/20 Onsite have?

20/20 Onsite has 11-50 employees.

20/20 Onsite

Point-of-need ophthalmic clinical trial solutions

United States · $8.0M raised

Healthcare

Employees: 11–50
Business Model: B2B
Website: 2020onsite.com

Total Funding: $8.0M
Last Round: $8.0M Series AMay 2021
Rounds: 4

About

20/20 Onsite is a specialty clinical research organization providing end-to-end ophthalmic assessment services for sponsors and CROs conducting clinical trials with ocular endpoints. The company operates a nationwide fleet of point-of-need mobile ophthalmic units, enabling decentralized trial participation by bringing eye exams directly to patients rather than requiring them to travel to traditional clinical sites. With over 100,000 eye exams performed and 45+ clinical trials supported, 20/20 Onsite delivers single-call accountability for ocular endpoints across Phase 1 through Phase 3 studies, powered by a network of licensed optometrists.

Summary

20/20 Onsite is a Healthcare company based in United States. It has raised $8.0M in total across 4 rounds, most recently a $8.0M Series A round in May 2021. Investors include Morningside Group.